Citadel Advisors
NMTR

Citadel Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Citadel Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,700
Closed -$15.3K – 15596
2023
Q2 		$15.3K Sell
22,700
-3,200
-12% -$2.83K ﹤0.01% 12958
2023
Q1 		$36K Buy
25,900
+13,730
+113% +$25.9K ﹤0.01% 12553
2022
Q4 		$15.3K Buy
12,170
+11,155
+1,099% +$25.4K ﹤0.01% 13335
2022
Q3 		$4K Sell
1,015
-780
-43% -$3.87K ﹤0.01% 12395
2022
Q2 		$9K Sell
1,795
-6,085
-77% -$57.3K ﹤0.01% 12619
2022
Q1 		$94K Buy
7,880
+2,450
+45% +$33.5K ﹤0.01% 12349
2021
Q4 		$106K Sell
5,430
-2,135
-28% -$47.8K ﹤0.01% 12666
2021
Q3 		$197K Buy
7,565
+2,185
+41% +$51.5K ﹤0.01% 12008
2021
Q2 		$118K Sell
5,380
-455
-8% -$11.2K ﹤0.01% 12766
2021
Q1 		$137K Sell
5,835
-1,150
-16% -$35.3K ﹤0.01% 12154
2020
Q4 		$120K Buy
6,985
+5,845
+513% +$97.5K ﹤0.01% 10103
2020
Q3 		$19K Buy
1,140
+435
+62% +$5.27K ﹤0.01% 9875
2020
Q2 		$8K Sell
705
-370
-34% -$4.17K ﹤0.01% 9656
2020
Q1 		$11K Buy
+1,075
New +$13.5K ﹤0.01% 9415
2019
Q1 		– Sell
-595
Closed -$27K – 10064
2018
Q4 		$27K Sell
595
-450
-43% -$33.3K ﹤0.01% 8657
2018
Q3 		$143K Buy
+1,045
New +$180K ﹤0.01% 8429

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Citadel Advisors's NMTR Position: Q3 2023 in Review

Citadel Advisors sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 1,388 shares — an estimated $933 sold.

Citadel Advisors first reported a position in NMTR in Q4 2016 and held it in 16 quarters. The position peaked at $259K in Q1 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Citadel Advisors reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,388 9 Meters Biopharma shares in Q3 2023, an estimated $933.
  • Citadel Advisors first reported a position in 9 Meters Biopharma in Q4 2016 and held it in 16 quarters.
  • Citadel Advisors's 9 Meters Biopharma position peaked at $259K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.